Navigation Links
Contaminated Surgical Instruments Increase Risk Of Infections

NHS advisers warned that hospitals are repeatedly failing to implement rules that will reduce the risk of fatal infections passed to patients //from contaminated surgical instruments.

The report said that surgical teams are not keeping instruments in sets so they can be traced easily. Instead kits are being swapped for operations, they allege.

Dr Gill Morgan, chief executive of the NHS Confederation, said it was vital to see that surgical instruments were not contaminated and if they were care should be taken to ensure that they were cleaned properly before reuse. 'There is currently much debate across health services in Europe about the use of single and multiple-use surgical instruments,' she said.

"Many professionals, including doctors and managers, feel that manufacturers are often overly cautious in their instructions on the use of surgical instruments and are challenging the guidance on single-use instruments," she added.

A Department of Health spokeswoman said that the breach was serious and should be taken care of immediately.
'"/>




Page: 1

Related medicine news :

1. Contaminated Land Can Be Cleaned By Micro-Organisms
2. Parents Warned About Contaminated Teething Rings By FDA
3. Eating Contaminated Food Leads To Cholera Outbreak In Malawi
4. Kids Fall Ill After Consuming Ricin-Contaminated Castor Beans in China
5. Public Requested To Discard Cheese Products Contaminated With Salmonella
6. Contaminated Water Hits Thousands In Pakistan City
7. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
8. Sanitizer For Contaminated Sprouts Developed
9. Fear Over Maple Leaf Meat Being Contaminated
10. Dye-Contaminated Fish From Guangdong
11. FDA Urgently Warns Consumers About Health Risks of Potentially Contaminated Olives
Post Your Comments:
(Date:5/21/2008)...y 21 /PRNewswire-FirstCall/ -- Aflac Incorporated,...presentation at the Sanford,C. Bernstein & Co., LL...nce,2008., President and Chief Financial Officer ...ted, and he is scheduled to make a presentation on...orated presentation, Mr.,Cloninger will discuss th...
(Date:5/21/2008)...d SILVER SPRING, Md., May 21 /PRNewswire-USNewswir... (ADAA),( http://www.adaa.org ) and The HealthCent... announced that ADAA will join,HealthCentral,s gro...and,health experts dedicated to helping people suf... advice and support they need to cope with the,con...
(Date:5/21/2008)...s 1st quarter profit, enhanced operations and new ...ELES, May 21 /PRNewswire-FirstCall/ -- InstaCare C...butor of at-home testing diagnostics,for the chron...eveloper of,patent-pending technologies for e-heal...s for the first quarter period-ended March 31, 200...
(Date:5/21/2008)... Adverse Events in TORCH Showed Frequency Highest ...ONTO and RESEARCH TRIANGLE PARK, N.C., May 21 /PRN...500/50 (fluticasone propionate and,salmeterol inha...er of,cardiovascular adverse events compared to ot...from the TOwards a Revolution in COPD Health,(TORC...
Breaking Medicine News(10 mins):Health News:Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 4Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 5Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 2Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 3
...es from the saliva may be the biomarkers that can ...eople. These biomarkers are called salivary trans...e researchers have been able to successfully predi... of ten people. The UCLA team has developed ways t...
...ems to be entrenched in the brain development of t... for Neurological Research, Buenos Aires, Argentin...y not be able to help but gamble. According to the...ecision making abilities of 11 spontaneous gambler...
...ith or without breast feeding, weight gain in the ...ty, says a current study. Babies who are raised on...om the first week after birth only. This weight ga...d to a strong tendency of becoming obese for life....
... waistline, along with the elevated levels of trig...nesis and cardiac problems for post menopausal wom...s to estimate the risk of cardiovascular mortalit...is. Atherogenesis is the process of plaques etc fo...
Other Medicine News:
(Date:5/21/2008)...RNewswire/ -- Alba Therapeutics Corporation,announ...ial were presented,in the Clinical Advances in Cel...(DDW) meeting in San Diego, California. Results of... study of larazotide acetate for the,prevention of...n celiac,subjects in remission(1) were presented b...
(Date:5/21/2008)...J., May 21 /- Genta,Incorpo...ltiple abstracts,featuring its lead oncology produ... the American Society of Clinical Oncology (ASCO) ...ts include the following:, -- Initial Phase 1 Cl... oral gallium-containing Compound. Poster # 5...
(Date:5/21/2008)...Fibrosis Patients Cough More Than 600 Times Per Da...NFIELD, N.J., May 21 /- PTC Therapeut...g that the quantification of cough,frequency may o...stic,fibrosis (CF). Cough is one of the most promi.... According to data presented today at the,2008 In...
(Date:5/21/2008)...sents OrBIT Study Results Comparing Percutaneous, ...py at the 2008 American Urological.../- Uroplasty, Inc. (Amex:,U...actures and markets,innovative proprietary product...highlighted results from the OrBIT trial of its Ur...
Breaking Medicine Technology:Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 2Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 3Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 4Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 5Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology 2Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology 3PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 2PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 3PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 4Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System 2Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System 3Connecticut Bioscience Achievement Awards Presented at CURE Annual Meeting 7656 1Connecticut Bioscience Achievement Awards Presented at CURE Annual Meeting 7656 2HHS Marks Expansion of 1200th Health Center Meeting Key Bush Goal 7652 1HHS Marks Expansion of 1200th Health Center Meeting Key Bush Goal 7652 2URAC Names Sensei for Weight Loss as a Finalist in First Ever Best Practices in Consumer Empowerment and Protection Awards 7648 1URAC Names Sensei for Weight Loss as a Finalist in First Ever Best Practices in Consumer Empowerment and Protection Awards 7648 2URAC Names Sensei for Weight Loss as a Finalist in First Ever Best Practices in Consumer Empowerment and Protection Awards 7648 3Newly HIV Infected Gay Men Select Other Infected Partners 7644 1Newly HIV Infected Gay Men Select Other Infected Partners 7644 2
...ination , , , , , PARSIPPANY, NJ,(May 21, 2007) ...ne besylate with the angiotensin receptor blocker,...ductions in,seated systolic and diastolic blood pr... data presented at the American Society,of Hyperte...ing and,Exposition (ASH 2007). The Phase III regi...
...HD Patients Nearly Triple That,of General Populati...ANAPOLIS, May 23, 2007 /PRNewswire-FirstCall/ -- D...R) (atomoxetine HCl),improved symptoms of Attentio...ts with comorbid alcohol abuse disorder, suggestin...Strattera in,patients with both disorders. Results...
Other Medicine Technology:Amlodipine and Olmesartan Study Results Released;Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 2Amlodipine and Olmesartan Study Results Released;Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 3Amlodipine and Olmesartan Study Results Released;Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 4Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 2Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 3Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 4Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 5Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 6
Malaria Pf. Assay Range
An immunochromatographic test for detection of 4 species of Plasmodium antigen ( P. falciparum , P. vivax , P. malariae , P. ovale ) in whole blood.
192 Test HRP-II Enzyme Immunoassay for the presence of Plasmodium falciparum infection.
Malaria device / strip (3 line, PAN-pLDH, P.f.-HRP2)
Medicine Products: